All tenders
W911SR23F0057
DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE/STABILITY FOR THE PROGRAM WITH ULTIMATE GOAL OF U.S. F.D.A. LICENSURE OF BONT MAB G03-52-01 DRUG PRODUCT.
Department of the Army · United States
This tender closed on Wednesday, January 5, 2028. Browse open opportunities
Time Left to Bid
Closed
ClosedDefence & SecurityFederal
Basic information
- Reference number
- W911SR23F0057
- Issuing organization
- Department of the Army · Find award history →
- Government level
- Federal
- Solicitation type
- Defence & Security
- Title
- DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE/STABILITY FOR THE PROGRAM WITH ULTIMATE GOAL OF U.S. F.D.A. LICENSURE OF BONT MAB G03-52-01 DRUG PRODUCT.
- Source
- USASpending (Federal)
- Source ID
- usa-W911SR23F0057
Details
- Location
- United States
Description
DRUG SUBSTANCE (DS) PROCESS VALIDATION, DRUG PRODUCT (DP) PROCESS VALIDATION, CLINICAL DEVELOPMENT PHASE 3, AND STORAGE/STABILITY FOR THE PROGRAM WITH ULTIMATE GOAL OF U.S. F.D.A. LICENSURE OF BONT MAB G03-52-01 DRUG PRODUCT. Awarded to: RESILIENCE GOVERNMENT SERVICES, INC. Agency: Department of Defense Sub-agency: Department of the Army Award type: DELIVERY ORDER
Dates
- Publication
- 2023/03/07 12:00:00 AM UTC
- Closing date
- 2028/01/05 12:00:00 AM UTC
Estimated value
$4.3M USD
Classification
Normalized category
Defence & Security